Distinct Morphological Features Predictive for Aggressiveness of Papillary Thyroid Microcarcinoma: a Study of 72 Cases and 80 Tumor Foci

1. DeLellis RA, Williams ED. Pathology of the thyroid and parathyroid. 2004;2:57-66.Search in Google Scholar

2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317-322.10.1001/jamaoto.2014.1Search in Google Scholar

3. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States. 1973-2002. JAMA. 2006;295(18):2164-2167.10.1001/jama.295.18.2164Search in Google Scholar

4. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics. 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18(3):784-791.10.1158/1055-9965.EPI-08-0960Search in Google Scholar

5. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.10. http://globocan.iarc.fr. 2010.Search in Google Scholar

6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S. 1985-1995. Cancer. 1998;83(12):2638-2648.10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1Search in Google Scholar

7. Sassolas G, Hafdi-Nejjari Z, Remontet Let al. Thyroid cancer: is the incidence rise abating? Eur J Endocrinol. 2009;160(1):71-79.10.1530/EJE-08-0624Search in Google Scholar

8. Cătană R, Boilă A, Haifa Bet al. Time trends in thyroid pathology - a 20 year retrospective study. Acta Medica Marisiensis. 2010;56(6):534-537.Search in Google Scholar

9. Hughes DT, Haymart MR, Miller BSet al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid. 2011;21(3):231-236.10.1089/thy.2010.0137Search in Google Scholar

10. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid. 2014;24(3):472-479.10.1089/thy.2013.0257Search in Google Scholar

11. Li N, Du XL, Reitzel LRet al. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid. 2013;23(1):103-110.10.1089/thy.2012.0392Search in Google Scholar

12. Yu XM, Wan Y, Sippel RS, Chen H. Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg. 2011;254(4):653-660.10.1097/SLA.0b013e318230036dSearch in Google Scholar

13. Pacini F. Management of papillary thyroid microcarcinoma: primum non nocere! J Clin Endocrinol Metab. 2013;98(4):1391-1393.Search in Google Scholar

14. Piana S, Ragazzi M, Tallini Get al. Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis. Hum Pathol. 2013;44(4):556-565.10.1016/j.humpath.2012.06.019Search in Google Scholar

15. Page C, Biet A, Boute Pet al. ‘Aggressive papillary’ thyroid microcarcinoma. Eur Arch Otorhinolaryngol. 2009;266(12):1959-1963.10.1007/s00405-009-0952-519294400Search in Google Scholar

16. Virk RK, Van Dyke AL, Finkelstein Aet al. BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. Mod Pathol. 2013;26(1):62-70.10.1038/modpathol.2012.15222918165Search in Google Scholar

17. Virk RK, Theoharis CG, Prasad Aet al. Morphology predicts BRAF (V600E) mutation in papillary thyroid carcinoma: an interobserver reproducibility study. Virchows Arch. 2014;464(4):435-442.10.1007/s00428-014-1552-324549591Search in Google Scholar

18. Niemeier LA, Kuffner AH, Song Cet al. A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. Cancer. 2012;118(8):2069-2077.10.1002/cncr.26425322964921882177Search in Google Scholar

19. Rossi ED, Bizzarro T, Fadda Get al. Is morphology alone able to predict BRAF-mutated malignancies on thyroid FNAC? Virchows Arch. 2014; 465(2):247-8;10.1007/s00428-014-1607-524928715Search in Google Scholar

20. Liu Z, Wang L, Yi Pet al. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis. Int J Clin Exp Pathol. 2014;7(3):932-937.Search in Google Scholar

21. Hsiao SJ, Nikiforov YE. Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer. 2014;21(5):T301-T313.10.1530/ERC-14-0166416036924829266Search in Google Scholar

22. Lin KL, Wang OC, Zhang XHet al. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol. 2010;17(12):3294-3300.10.1245/s10434-010-1129-620953721Search in Google Scholar

23. Rossi ED, Bizzarro T, Martini Met al. Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Cancer Cytopathol. 2014;122(12):883-891.10.1002/cncy.2147525156883Search in Google Scholar

24. Finkelstein A, Levy GH, Hui Pet al. Papillary thyroid carcinomas with and without BRAF V600E mutations are morphologically distinct. Histopathology. 2012;60(7):1052-1059.10.1111/j.1365-2559.2011.04149.x22335197Search in Google Scholar